Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University
About this trial
* To evaluate efficacy of intratympanic injection of dexamethasone and hyaluronic acid mixture as a treatment modality in cases of sudden sensorineural hearing loss (SSNHL). * To compare outcomes of intratympanic injection of dexamethasone and hyaluronic acid mixture to dexamethasone alone in treatment of SSNHL.
Eligibility criteria
Qualifiers
Adult patients (aged 18 and over)
Patients with sudden sensory neural hearing loss (SSNHL)
Disqualifiers
Patients with middle or external ear pathology.
Patient with history of traumatic skull base fracture.
Patients with previous ear surgery.
Patients with other neurological symptoms or signs (Other cranial nerves affection).
Trial design
Treatments tested in this trial
- Hyaluronic Acid (HA)
- Dexamethasone
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov